Nishiwaki Y | Division Of Thoracic Oncology National Cancer Center Hospital East
スポンサーリンク
概要
- NISHIWAKI Yutakaの詳細を見る
- 同名の論文著者
- Division Of Thoracic Oncology National Cancer Center Hospital Eastの論文著者
関連著者
-
Tamura T
Division Of Internal Medicine National Cancer Center Hospital
-
Saijo N
Division Of Internal Medicine National Cancer Center Hospital East
-
Saijo Nagahiro
国立医薬品食品衛生研究所
-
Saijo N
Medical Oncology National Cancer Center Hospital
-
Tamura Tomohide
国立がんセンター中央病院 腫瘍内科
-
Tamura T
National Cancer Center Hospital Tokyo
-
Tamura Tomohide
Medical Oncology Division National Cancer Center Hospital
-
NISHIWAKI Yutaka
Division of Thoracic Oncology, National Cancer Center Hospital East
-
Nishiwaki Y
Division Of Thoracic Oncology National Cancer Center Hospital East
-
Tagawa Toshiaki
国立がんセンター中央病院 消化器内科
-
Tamura Tomohide
Division Of Internal Medicine National Cancer Center Hospital
-
Nakaya Y
Division Of Thoracic Oncology National Cancer Center Hospital East
-
Nishiwaki Yutaka
Division Of Thoracic Oncology National Cancer Center Hospital East
-
Yoshida Shigeaki
国立がんセンター東病院 消化管内科
-
TAMURA Tomohide
Division of Internal Medicine, National Cancer Center Hospital
-
Ohe Yuichiro
国立医薬品食品衛生研究所
-
Ohe Yuichiro
Thoracic Oncology Division National Cancer Center Hospital National Cancer Center
-
Ohe Yuichiro
Department Of Medical Oncology National Cancer Center Hospital
-
Ohe Yuichiro
Department Of Internal Medicine National Cancer Center Hospital
-
Ohno Yasuo
Division Of Pharmacology National Institute Of Health Sciences
-
OHTSU Tomoko
Amgen Limited
-
SASAKI Yasutsuna
Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
-
SEKINE Ikuo
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital
-
Saijo Nagahiro
Pharmacology Division, National Cancer Center Research Institute
-
Ohno Y
Division Of Pharmacology National Institute Of Health Sciences
-
Ohno Y
Natl. Inst. Health Sci.
-
Ohno Yasuo
Div. Of Pharmacology Biological Safty Research Center National Institute Of Hygienic Sciences
-
Ohe Yuichiro
Division Of Internal Medicine And Thoracic Oncology National Cancer Center Hospital
-
Saijo Nagahiro
Department Of Internal Medicine National Cancer Center Hospital
-
Saijo Nagahiro
Pharmacology Division National Cancer Center Research Institute
-
OHTSU Tomoko
Hematology and Oncology, National Cancer Center Hospital East
-
Sasaki Yasutsuna
Div. of Oncol.
-
Tamura Tomohide
Div. of Oncol.
-
Nakanomyo Hiroshi
Hoematol.
-
Nishiwaki Yutaka
Bristol-Mayers Squibb K.K., Div. of Resp. Dis. & Pharmacol. Dive.
-
Saijo Nagahiro
Natl. Cancer Ctr. Hosp. East, Kanagawa Lab.
-
SEKINE Ikuo
Department of medical Oncology, National Cancer Center Hospital National Cancer Center Research
-
TAMURA Tomohide
Department of medical Oncology, National Cancer Center Hospital National Cancer Center Research
-
Sasaki Yasutsuna
Division Of Oncology And Hematology National Cancer Center Hospital East
-
ISHIZUKA Naoki
Cancer Information & Epidemiology Division, National Cancer Center Research Institute
-
the Japan
Department of Internal Medicine, National Cancer Center Hospital
-
Ishizuka N
Cancer Information & Epidemiology Division National Cancer Center Research Institute
-
Omori Yoshihito
Division Of Pharmacology National Institute Of Hygienic Sciences
-
Omori Yoshihito
Division Of Pharmacology Biological Safety Research Center National Institute Of Hygienic Sciences:d
-
Ohno Yasuo
National Inst. Of Health Sci. Tokyo Jpn
-
Ohtsu Tomoko
Division Of Oncology/hematology National Cancer Center Hospital East
-
Sekine Ikuo
Department Of Internal Medicine National Cancer Center Hospital
-
Ohno Yasuo
Division Of Internal Medicine And Thoracic Oncology National Cancer Center Hospital
-
Okamoto Yuko
Department Of Internal Medicine National Cancer Center Hospital
-
Ohe Y
National Cancer Center Hospital Tokyo
-
Sasaki Yasutsuna
Division Of Hematology And Oncology National Cancer Center Hospital East
-
The Japan
Department Of Internal Medicine National Cancer Center Hospital
著作論文
- What is the most informative pharmacodynamic model for paclitaxel (T)? : a 3 hour-infusion vs. 24-hour infusion.
- Long-term follow-up of patients with unresectable locally advanced non-small cell lung cancer treated with chemoradiotherapy: A retrospective analysis of the data from the Japan Clinical Oncology Group trials (JCOG0003A)
- Phase I Study of Paclitaxel by Three-hour Infusion : Hypotension Just after Infusion Is One of the Major Dose-limiting Toxicities